Back to results
US 2004/0023942 A1Published application
Novel, water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
AssigneeZentaris AG
InventorsKarl-Christian Bart, Guenther Bernhardt, Henri Brunner, Christian Lottner
Life of this patent
Estimating the term…
Abstract
The invention relates to novel, water-soluble porphyrin platinum compounds of the tetraarylporphyrin platinum derivatives type or of the hematoporphyrin platinum derivatives type with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases. In particular, the compounds are suitable for photodynamic anti-tumor therapy.
Claims8
Porphyrin platinum derivatives of the
- (a) tetraarylporphyrin platinum derivatives type according to formula I
- 8
- and according to formula II
- 9
- and
- (b) hematoporphyrin platinum derivatives type
- according to formula III
- 10
- and according to formula IV
- 11
7 more elements
Dependencies are inferred from the claim text.